Stay updated on SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A government funding lapse notice is now displayed on the page, and the site revision tag has been updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T01:28:54.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Glossary visibility was added and QC-related labels were updated to show the new revision (v3.4.0), replacing the previous version and capitalization variants.
    Difference
    0.2%
    Check dated 2026-01-27T23:54:36.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces the previous v3.3.3 on the page; no substantive changes to study details or eligibility criteria are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T01:55:47.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    A dedicated Locations section has been added listing sites by state (Arizona, Maryland, Oregon, Texas). The previous state-specific subsections were removed, indicating a reorganization of site listings.
    Difference
    0.5%
    Check dated 2025-12-23T10:10:41.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the page.
    Difference
    0.0%
    Check dated 2025-11-24T21:19:06.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and potential updates/response delays has been removed from the page. This change does not affect the trial details, eligibility criteria, or study results presented on the NCT03238027 page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T18:44:02.000Z thumbnail image

Stay in the know with updates to SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.